Lataa...
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...
Tallennettuna:
Päätekijät: | , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
MDPI AG
2020-10-01
|
Sarja: | Cancers |
Aiheet: | |
Linkit: | https://www.mdpi.com/2072-6694/12/10/2993 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|